PharmStockPharmacy Stock

Kytril
Kytril

3.22
A generic medicine indicated for oncology care. Addresses feelings of nausea and vomiting by blocking signals transmitted to the brain's control centre.
Ingredient
Granisetron
Category
Oncology Support
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Granisetron
Reference Brand
Granisetron
Product Origin
Generic Alternative
Reference Manufacturer
Roche
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
5-HT3 Receptor Antagonist
Pharmacological Class
Antiemetic
Manufacturer Description
Intended to relieve severe treatment-induced emesis to support nutritional intake during clinical oncology therapies.
Mechanism of Action
Blocks peripheral and central 5-HT3 receptors on vagal nerve terminals and the chemoreceptor trigger zone in brain tissues.
Route of Administration
Oral
Onset Time
1 hour
Duration
12–24 hours
Contraindications
Hypersensitivity to granisetron
Severe Adverse Events
QT prolongation — requires immediate medical attention, Serotonin syndrome — requires immediate medical attention
Common Side Effects
Headache, Constipation, Fatigue
Uncommon Side Effects
Transient elevated transaminases, Diarrhea, Dizziness
Drug Interactions
Apomorphine, QT-prolonging drugs
Pregnancy Safety Warnings
TGA Category B: Safety confirmed in animal studies. Breastfeeding: Consult a clinician.
Age Restrictions
Approved for children and adults.
Storage Guidelines
Store below 25°C.
Related Products
Zofran
Information related to Kytril is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order ED Pills Online - Tadalafil Daily ED Tablet AU